General Information of Drug (ID: DM95FR3)

Drug Name
Tarextumab Drug Info
Indication
Disease Entry ICD 11 Status REF
Pancreatic cancer 2C10 Phase 2 [1]
Small-cell lung cancer 2C25.Y Phase 2 [2]
Cross-matching ID
TTD Drug ID
DM95FR3

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Notch-2 receptor (NOTCH2) TT82FVD NOTC2_HUMAN Modulator [3]
Notch-3 receptor (NOTCH3) TTVX7IA NOTC3_HUMAN Modulator [3]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8453).
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Company report (OncoMed Pharmaceuticals)